Results 111 to 120 of about 13,203 (228)

Zinc treatment for hyposmia and motor dysfunction in PD patients

, 2011
Parkinson-Patienten weisen erniedrigte Zink-Spiegel im Liquor auf und zeigen Symptome eines funktionellen Zinkmangels. Zinkmangel macht sich für gewöhnlich in einer gestörten Geruchsempfindung bemerkbar.
Krug, Julika (13215465X)
core   +1 more source

The Spectrum of Congenital Hypogonadotropic Hypogonadism: A 30‐Year Experience at a Tertiary Paediatric Centre

Clinical Endocrinology, Volume 105, Issue 4, Page 464-473, October 2026.
ABSTRACT Congenital hypogonadotropic hypogonadism (CHH) is a rare group of disorders of gonadotropin deficiency, either isolated or as a part of multiple pituitary hormone deficiencies (MPHD). We aimed to describe the spectrum of presentation, diagnosis, and management practices of CHH spanning 30 years at an Australian tertiary paediatric centre. This
Minha Kook, Richard G. McGee, Geoffrey Ambler, Yoon Hi Cho   +3 more
wiley   +1 more source

Using SCENTinel® to predict SARS-CoV-2 infection: insights from a community sample during dominance of Delta and Omicron variants

Frontiers in Public Health
IntroductionBased on a large body of previous research suggesting that smell loss was a predictor of COVID-19, we investigated the ability of SCENTinel®, a newly validated rapid olfactory test that assesses odor detection, intensity, and identification ...
Stephanie R. Hunter, Anne Zola, Emily Ho, Michael Kallen, Edith Adjei-Danquah, Chad Achenbach, G. Randy Smith, Richard Gershon, Danielle R. Reed, Benjamin Schalet, Valentina Parma, Pamela H. Dalton   +11 more
doaj   +1 more source

Hyposmia

British Journal of Hospital Medicine, 2015
Syed, Irfan, Philpott, Carl
openaire   +4 more sources

CSF Monoamine Metabolites and Cognitive Trajectory in Early Parkinson's Disease

Annals of Clinical and Translational Neurology, Volume 13, Issue 9, Page 1842-1850, September 2026.
ABSTRACT Background Imaging and postmortem studies indicate that abnormalities in monoaminergic neurotransmission contribute to cognitive impairment in Parkinson's disease (PD). However, it remains uncertain if cerebrospinal fluid (CSF) monoamine metabolites can serve as biomarkers of cognitive decline in early PD.
Jing‐Yu Shao, Rong Li, Yu‐Xiang Jiao, Kai Ma, Hong‐Qi Yang, Zheng‐Yu Sun, Jie‐Wen Zhang, Shuai Chen   +7 more
wiley   +1 more source

Hyposmia in G2019S LRRK2-related parkinsonism - Clinical and pathologic data

, 2008
Background: Mutations in PARK8 (LRRK2) are associated with autosomal dominant parkinsonism and Parkinson disease (PD). Hyposmia is present in at least 80% of patients with PD and an accumulation of alpha-synuclein (alpha-syn) is seen in the olfactory ...
Sampaio, C, Bonifati, Vincenzo, Shaw, K, Kingsbury, A, Guedes, LC, Abou-Sleiman, P, Holton, J, Quinn, NP, Revesz, T, Ferreira, JJ, Wood, NW, Petrie, A, Silveira-Moriyama, L, Lees, AJ, Barbosa, ER, Ayling, H   +15 more
core   +1 more source

Chronic Rhinosinusitis and Nasal Polyps in Eosinophilic Granulomatosis With Polyangiitis: A Scoping Review

International Forum of Allergy &Rhinology, Volume 16, Issue 9, Page 996-1011, September 2026.
ABSTRACT Background Chronic rhinosinusitis (CRS) is one of the most common manifestations of eosinophilic granulomatosis with polyangiitis (EGPA), often preceding the diagnosis of systemic vasculitis by several years. The sinonasal presentation of EGPA typically resembles CRS with nasal polyps (CRSwNP), making it clinically indistinguishable from those
Alisha Sharma, Alyssa Y. Li, Teruko Kishibe, Dennis Wong, Kevin M. Sanders, Maggie Jiang, Heedo Lee, Christine Song, Kieran Mcintyre, Christian Pagnoux, Yvonne Chan, John M. Lee, Daniel J. Lee   +12 more
wiley   +1 more source

Demographics, clinical, and DAT SPECT characteristics in the PD, RBD, Hyposmia, and non-PD mutation carrier groups.

, 2018
Demographics, clinical, and DAT SPECT characteristics in the PD, RBD, Hyposmia, and non-PD mutation carrier groups.
Irene Richard (4030643), Christopher S. Coffey (241836), Paolo Barone (436053), Daniel Weintraub (575964), Shirley Lasch (4030637), Chelsea Caspell-Garcia (4030664), Dag Aarsland (157629), Roy Alcalay (733324), Keith A. Hawkins (4030640), Tanya Simuni (4030655), David Burn (4030649), Jamie L. Hamilton (5646032), James B. Leverenz (241710), Irene Litvan (2839049), Andrew Siderowf (4030646), Lana M. Chahine (4030661), Liz Urbe (5646029), Alberto J. Espay (139508)   +17 more
core   +1 more source

Atmospheric Aerosol Neurotoxicity and Parkinson's Disease: Mechanisms and Perspectives

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
Schematic overview of the pathways and pathological mechanisms connecting atmospheric aerosol exposure to PD. Atmospheric aerosols, including PM2.5 and nanometer/ultrafine particles loaded with metal particles, persistent organic pollutants (POPs), polycyclic aromatic hydrocarbons (PAHs) and dioxins, enter the body predominantly via pulmonary ...
Yitian Gao, Minxiang Dong, Chenyang Duan, Xiaohan Zheng, Liming Qu   +4 more
wiley   +1 more source

Icariside II in Neurological Disorders: Mechanistic Insights Into Alzheimer's Disease, Cerebral Ischemia and Parkinson's Disease

Journal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
The graphical abstract represents the underlying neuroprotective potential of ICS II against Alzheimer's disease, Cerebral ischemia and Parkinson disease. ICS II downregulates ROS production, inflammation, mitochondrial dysfunction and apoptosis along with regulating their key signalling pathways.
Ashutosh Solanki, Khushi Sharma, Jagrati Jain, Niraj Kumar Singh, Praveen T. Krishnamurthy   +4 more
wiley   +1 more source